Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Operating Expenses (2009 - 2025)

Grifols' (GIFLF) quarterly Operating Expenses came in at -$1.9 million in Q4 2025, down 6.94% on a YoY basis from -$2.0 million in Q4 2024, and down 6.94% quarter-over-quarter from -$1.8 million in Q4 2024.

Analysis

Grifols (GIFLF) Operating Expenses (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Operating Expenses for 17 consecutive years, with -$1.9 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses fell 6.94% year-over-year to -$1.9 million; the trailing twelve-month figure through Dec 2025 stood at -$1.9 billion (down 6.97% YoY), and the FY2025 full-year result was -$1.8 billion, down 3.79% from the prior year.
  • Operating Expenses retreated to -$1.9 million in Q4 2025 per GIFLF's latest filing, from -$1.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $122.3 million in Q4 2021 and bottomed at -$1.9 billion in Q4 2023.
  • Historically, Operating Expenses has averaged -$356.7 million across 5 years, with a median of -$1.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 5168671.1% in 2023, then surged 99.91% in 2024.
  • Over 5 years, Operating Expenses stood at $122.3 million in 2021, then sank by 99.97% to $36804.4 in 2022, then sank by 5168671.1% to -$1.9 billion in 2023, then soared by 99.91% to -$1.8 million in 2024, then retreated by 6.94% to -$1.9 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods registered -$1.9 million, -$1.8 million, and -$1.9 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -1.05 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 1.06 Bn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 367.83 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -1.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.87 Mn
Dec 31, 2024 -1.75 Mn
Dec 31, 2023 -1.90 Bn
Dec 31, 2022 36,804.40
Dec 31, 2021 122.26 Mn
Dec 31, 2020 120.91 Mn
Mar 31, 2020 -351.55 Mn
Dec 31, 2019 -993.06 Mn
Mar 31, 2019 -337.55 Mn
Dec 31, 2018 -1.20 Bn
Jun 30, 2018 305.20 Mn
Mar 31, 2018 -300.11 Mn
Dec 31, 2017 -1.35 Bn
Jun 30, 2017 303.67 Mn
Mar 31, 2017 -308.10 Mn
Dec 31, 2016 -275.62 Mn
Sep 30, 2016 254.98 Mn
Jun 30, 2016 278.46 Mn
Mar 31, 2016 103.56 Mn
Dec 31, 2015 -1.81 Bn